Nutex Health Inc.
NUTX
$131.90
-$3.58-2.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 295.53% | -78.65% | 598.79% | -152.38% | -65.56% |
| Total Depreciation and Amortization | 5.88% | 3.68% | -4.67% | 3.06% | -3.58% |
| Total Amortization of Deferred Charges | -77.40% | -42.06% | 0.40% | -0.79% | 6.75% |
| Total Other Non-Cash Items | 400.65% | -104.48% | -19.05% | 85.95% | 31.48% |
| Change in Net Operating Assets | -78.78% | 230.65% | 36.77% | -127.18% | 72.10% |
| Cash from Operations | 7.29% | -29.27% | 265.10% | -46.52% | 94,279.63% |
| Capital Expenditure | 67.78% | -1,134.11% | 89.00% | -4,189.06% | 83.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -- | -- |
| Cash from Investing | 76.32% | -1,579.47% | -254.08% | 406.25% | 98.08% |
| Total Debt Issued | -- | -160.40% | -46.38% | -79.04% | 255.84% |
| Total Debt Repaid | 58.26% | -26.22% | -37.15% | -47.65% | 34.56% |
| Issuance of Common Stock | 174.72% | 509.46% | -69.42% | -- | -- |
| Repurchase of Common Stock | -534.60% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 52.16% | -37.20% | -105.03% | -54.97% | -164.99% |
| Cash from Financing | -8.21% | -53.16% | -93.52% | -126.79% | -128.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26.85% | -71.83% | 477.43% | -72.77% | 803.40% |